This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04293/identifier/pdb/
n14http://bio2rdf.org/drugbank:
n11http://linked.opendata.cz/resource/drugbank/drug/DB04293/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB04293/identifier/pubchem-substance/
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04293/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB04293/identifier/chemspider/

Statements

Subject Item
n2:DB04293
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n7:DB04293 n14:DB04293
dcterms:title
7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid
adms:identifier
n9:46507072 n10:LOR n11:12897341 n12:3819 n13:DB04293
n3:IUPAC-Name
n4:271B4CC6-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4CCC-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4CCB-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4CC8-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4CC9-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4CCA-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4CC4-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4CC2-363D-11E5-9242-09173F13E4C5 n4:271B4CC5-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4CC3-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4CD2-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4CD3-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4CCD-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4CCE-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4CD0-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4CCF-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4CD1-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4CD8-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4CDA-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4CDB-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4CD7-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4CD6-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4CD9-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4CC7-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4CD4-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4CD5-363D-11E5-9242-09173F13E4C5